immunomodulatory proteins

You have access
Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone
JEROME H. CHECK, DIANE L. CHECK and NAOMI GANPO-NKEWNKWA

Anticancer Research February 2026, 46 (2) 1153-1165; DOI: https://doi.org/10.21873/anticanres.18018
You have access
New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor
JEROME H. CHECK and DIANE CHECK

Anticancer Research December 2021, 41 (12) 5873-5880; DOI: https://doi.org/10.21873/anticanres.15407

Main menu